Targeting oncogenic fusion genes in leukemias and lymphomas by RNA interferenceDAMM-WELK, Christine; FUCHS, Uta; WÖSSMANN, Wilhelm et al.Seminars in cancer biology. 2003, Vol 13, Num 4, pp 283-292, issn 1044-579X, 10 p.Article

The inhibition of angiogenesis by antisense oligonucleotides to clusterinJACKSON, John K; GLEAVE, Martin E; GLEAVE, Jacqueline et al.Angiogenesis (London). 2005, Vol 8, Num 3, pp 229-238, issn 0969-6970, 10 p.Article

Type II/III Runx2/Cbfal is required for tooth germ developmentKOBAYASHI, Ieyoshi; KIYOSHIMA, Tamotsu; WADA, Hiroko et al.Bone (New York, NY). 2006, Vol 38, Num 6, pp 836-844, issn 8756-3282, 9 p.Article

Ror1-Ror2 COMPLEXES MODULATE SYNAPSE FORMATION IN HIPPOCAMPAL NEURONSPAGANONI, S; BERNSTEIN, J; FERREIR, A et al.Neuroscience. 2010, Vol 165, Num 4, pp 1261-1274, issn 0306-4522, 14 p.Article

Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticlesWARTLICK, Heidrun; SPÄNKUCH-SCHMITT, Birgit; STREBHARDT, Klaus et al.Journal of controlled release. 2004, Vol 96, Num 3, pp 483-495, issn 0168-3659, 13 p.Article

Prolactin releasing peptide (PrRP) : An endogenous regulator of cell growthSAMSON, Willis K; TAYLOR, Meghan M.Peptides (New York, NY. 1980). 2006, Vol 27, Num 5, pp 1099-1103, issn 0196-9781, 5 p.Article

Asialoganglioside enhances the efficiency of gene transfection mediated by cationic liposomes with a cationic cholesterol derivativeNOGUCHI, Shoichiro; HIRASHIMA, Naohide; NAKANISHI, Mamoru et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 9, pp 1306-1310, issn 0918-6158, 5 p.Article

Local Dystrophin Restoration with Antisense Oligonucleotide PR0051VAN DEUTEKOM, Judith C; JANSON, Anneke A; DE KIMPE, Sjef J et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2677-2686, issn 0028-4793, 10 p.Article

Local Dystrophin Restoration with Antisense Oligonucleotide PR0051PLAISIER, Emmanuelle; GRIBOUVAL, Olivier; DRACON, Michel et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2687-2695, issn 0028-4793, 9 p.Article

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitisMINER, P. JR; WEDEL, M; BANE, B et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 3, pp 281-286, issn 0269-2813, 6 p.Article

FRET-FCS as a tool to evaluate the stability of oligonucleotide drugs after intracellular deliveryREMAUT, K; LUCAS, B; BRAECKMANS, K et al.Journal of controlled release. 2005, Vol 103, Num 1, pp 259-271, issn 0168-3659, 13 p.Article

Smart delivery of antisense oligonucleotides by anionic pH-sensitive liposomesFATTAL, Elias; COUVREUR, Patrick; DUBERNET, Catherine et al.Advanced drug delivery reviews. 2004, Vol 56, Num 7, pp 931-946, issn 0169-409X, 16 p.Article

Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic ResponsesGAUVREAU, Gail M; PHILIPPE BOULET, Louis; WATSON, Richard M et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 9, pp 952-958, issn 1073-449X, 7 p.Article

Oligonucleotide_-based therapy for neurodegenerative diseasesMAGEN, Iddo; HORNSTEIN, Eran.Brain research. 2014, Vol 1584, pp 116-128, issn 0006-8993, 13 p.Conference Paper

Evaluation of an ¹⁸F-Labeled Oligonucleotide Probe Targeting p21^WAF1 Transcriptional Changes in Human Tumor CellsKOSLOWSKY, I; SHAHHOSSEINI, S; MIRZAYANS, R et al.Oncology research. 2011, Vol 19, Num 6, pp 265-274, issn 0965-0407, 10 p.Article

Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: In vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cellsSIDDIQUI, Akhtar; PATWARDHAN, Gauri Anand; LIU, Yong-Yu et al.International journal of pharmaceutics (Print). 2010, Vol 400, Num 1-2, pp 251-259, issn 0378-5173, 9 p.Article

Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 regionIBI, Daisuke; NITTA, Atsumi; ISHIGE, Kumiko et al.Neurochemistry international. 2010, Vol 56, Num 1, pp 77-83, issn 0197-0186, 7 p.Article

Mcl-1 overexpression in hepatocellular carcinoma : A potential target for antisense therapySIEGHART, Wolfgang; LOSERT, Doris; WACHECK, Volker et al.Journal of hepatology. 2006, Vol 44, Num 1, pp 151-157, issn 0168-8278, 7 p.Article

Anti-miRNA oligonucleotides (AMOs) : ammunition to target miRNAs implicated in human disease?WEILER, J; HUNZIKER, J; HALL, J et al.Gene therapy (Basingstoke). 2006, Vol 13, Num 6, pp 496-502, issn 0969-7128, 7 p.Article

Oligonucleotide-based antiviral strategiesSCHUBERT, S; KURRECK, J.Handbook of experimental pharmacology. 2006, Vol 173, pp 261-287, issn 0171-2004, 27 p.Article

Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibitionOETTINGER, Carl W; D'SOUZA, Martin J.Journal of microencapsulation. 2012, Vol 29, Num 5, pp 455-462, issn 0265-2048, 8 p.Article

The roles of the α₁-adrenergic receptor subtypes in rat embryonic implantationDUCZA, Eszter; GASPAR, Robert; MIHALYI, Attila et al.Fertility and sterility. 2009, Vol 91, Num 4, pp 1224-1229, issn 0015-0282, 6 p.Article

Automated radiosynthesis of N-(4-[^l8F]fluorobenzyl)-2-bromoacetamide : an F-18-labeled reagent for the prosthetic radiolabeling of oligonucleotidesKOSLOWSKY, Ingrid; SHAHHOSSEINI, Soraya; WILSON, John et al.Journal of labelled compounds & radiopharmaceuticals. 2008, Vol 51, Num 9-10, pp 352-356, issn 0362-4803, 5 p.Article

Dendritic α,ε-poly(L-lysine)s as delivery agents for antisense oligonucleotides : Polymeric Carriers for Nucleic Acid DeliveryKHEE DONG EOM; SUN MI PARK; HUU DUNG TRAN et al.Pharmaceutical research. 2007, Vol 24, Num 8, pp 1581-1589, issn 0724-8741, 9 p.Article

Antisense molecules for targeted cancer therapyWACHECK, V; ZANGEMEISTER-WITTKE, U.Critical reviews in oncology/hematology. 2006, Vol 59, Num 1, pp 65-73, issn 1040-8428, 9 p.Article